• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体腺瘤的外科治疗。188例分析(作者译)

[Surgical treatment of pituitary adenomas. An analysis of 188 cases (author's transl)].

作者信息

Haguenauer J P, Goutelle A

出版信息

Ann Otolaryngol Chir Cervicofac. 1981;98(4-5):207-12.

PMID:7325515
Abstract

The authors report on a series of 188 patients operated upon for pituitary tumour. Since 12 operations were performed because of local recurrence, the total number of operations was 200 : 27 by the intracranial route and 173 by the naso-sphenoidal route. Four deaths (17%) followed surgery by the former route and three (1.8%) by the latter route. During the decade under review surgical indications have decreased for large tumours belatedly diagnosed and increased for micro-adenomas giving rise to endocrine symptoms only, notably prolactin-secreting adenomas. Improved knowledge of histopathology has resulted in the classification being altered : the conventional division into eosinophilic and chromophobe adenomas has been abandoned to be replaced by cellular types corresponding to the various hormone-producing and functional adenomas. Also a new type has appeared : oncocytoma. Secreting adenomas generally have a better prognosis than non-secreting adenomas, would it be only because they are smaller. Technical advances in operations almost exclusively performed nowadays by the naso-sphenoidal route have improved the results with regard to sight. Sight is now improved in 70.5% of the cases and completely restored in 32.4%.

摘要

作者报告了一系列188例接受垂体肿瘤手术的患者。由于因局部复发进行了12次手术,手术总数为200次:经颅内途径27次,经鼻蝶窦途径173次。前一种途径手术后有4例死亡(17%),后一种途径有3例死亡(1.8%)。在审查的十年中,对于诊断较晚的大肿瘤,手术指征有所减少,而对于仅引起内分泌症状的微腺瘤,特别是分泌催乳素的腺瘤,手术指征有所增加。对组织病理学认识的提高导致了分类的改变:传统的分为嗜酸性和嫌色性腺瘤的分类已被放弃,取而代之的是与各种产生激素的功能性腺瘤相对应的细胞类型。此外,还出现了一种新类型:嗜酸性细胞瘤。分泌性腺瘤的预后通常比非分泌性腺瘤好,这仅仅是因为它们较小。如今几乎完全通过鼻蝶窦途径进行的手术技术进步改善了视力方面的结果。现在70.5%的病例视力得到改善,32.4%的病例视力完全恢复。

相似文献

1
[Surgical treatment of pituitary adenomas. An analysis of 188 cases (author's transl)].垂体腺瘤的外科治疗。188例分析(作者译)
Ann Otolaryngol Chir Cervicofac. 1981;98(4-5):207-12.
2
[Recurrent adenoma of the hypophysis].[垂体复发性腺瘤]
Probl Endokrinol (Mosk). 1987 Nov-Dec;33(6):28-32.
3
[Follow up of 30 cases of prolactin -- or somatotropin -- secreting adenomas after trans-spenoidal surgery (author's transl)(proceedings)].经蝶窦手术后30例催乳素或生长激素分泌性腺瘤的随访(作者译)(会议论文)
Ann Endocrinol (Paris). 1976 Jul-Aug;37(4):283-4.
4
[The impact of surgical treatment on endocrinological status of pituitary adenomas associated with hyperprolactinemia (author's transl)].
No Shinkei Geka. 1982 Jan;10(1):55-62.
5
Diagnosis and treatment of pituitary adenomas.垂体腺瘤的诊断与治疗
Minerva Endocrinol. 2004 Dec;29(4):241-75.
6
[Surgical management of pituitary adenomas with preservation of pituitary function (author's transl)].保留垂体功能的垂体腺瘤手术治疗(作者译)
HNO. 1980 Mar;28(3):80-4.
7
Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome.基于影像学和激素结果比较经唇下显微手术入路(MSA)与鼻内镜下经鼻入路(EEA)治疗垂体腺瘤的疗效
Acta Neurochir Suppl. 2017;124:101-106. doi: 10.1007/978-3-319-39546-3_16.
8
Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.促甲状腺激素分泌型垂体腺瘤的临床病理特征及治疗结果:一项90例的单中心研究
J Neurosurg. 2014 Dec;121(6):1462-73. doi: 10.3171/2014.7.JNS1471. Epub 2014 Sep 19.
9
[Transsphenoidal microneurosurgery. Part 3. The morphology and endocrinological cure of functioning adenomas (author's transl)].
Neurol Med Chir (Tokyo). 1981 Sep;21(9):955-60.
10
[Growth hormone, prolactin, LH and FSH secretion in tissue culture of pituitary adenomas (author's transl)].垂体腺瘤组织培养中生长激素、催乳素、促黄体生成素及促卵泡生成素的分泌(作者译)
No Shinkei Geka. 1977 Oct;5(11):1135-41.